Private equity firm EQT launches $654 million cash bid for Sweden's Karo Pharma
Share:
STOCKHOLM (Reuters) - Private equity firm EQT on Monday made a recommended 5.97 billion Swedish crown (509.52 million pounds)cash bid to buy Swedish speciality pharma group Karo Pharma . The offer, made by the EQT VIII fund and unanimously recommended by Karo Pharma's board, represents a 25.3 percent premium to Karo's closing price on Friday. "We are delighted that the Board of Directors has decided to recommend EQT VIII's offer," EQT partner Per Franzen said in a statement."We are impressed..